Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Multivitamin
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Multivitamin + Probiotic Effect On Gut Health In GLP-1 Users
Details : Multivitamin is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 19, 2025
Lead Product(s) : Multivitamin
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : SPM Active
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Recipient : University of North Carolina, Chapel Hill
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of n-3 PUFA Monohydroxylated Derivatives in Obese Male Adults After Supplementation
Details : SPM Active is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 27, 2025
Lead Product(s) : SPM Active
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Recipient : University of North Carolina, Chapel Hill
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : ERr 731
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ERr 731® Formulation Evaluation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 25, 2023
Lead Product(s) : ERr 731
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : MetaProteomics LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
LIFEHOUSE: Description of the Tent Bucket -Immune Support
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
February 02, 2021
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : MetaProteomics LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cardiolux Hdl
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Nutritional Supplement Effect on HDL Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 27, 2020
Lead Product(s) : Cardiolux Hdl
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Hypertension Institute, Nashville
Deal Size : Inapplicable
Deal Type : Inapplicable
HDL Function Dietary Supplement Safety and QOL
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 20, 2019
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Hypertension Institute, Nashville
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : National University of Natural Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Prospective Tolerability Assessment of a Probiotic Dietary Supplement
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
August 05, 2019
Lead Product(s) : Probiotic
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : National University of Natural Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Tufts Medical Center | MetaProteomics LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 02, 2019
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Tufts Medical Center | MetaProteomics LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : RS blend
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Personalized Lifestyle Medicine Center | National University of Natural Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Resistant Starch Blend Gastrointestinal Impact
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 12, 2019
Lead Product(s) : RS blend
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Personalized Lifestyle Medicine Center | National University of Natural Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : SPM Active
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Queen Mary University of London
Deal Size : Inapplicable
Deal Type : Inapplicable
SPM Regulation by Fish Oil Supplements in Healthy Volunteers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 20, 2017
Lead Product(s) : SPM Active
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Queen Mary University of London
Deal Size : Inapplicable
Deal Type : Inapplicable